Electric Field-Responsive Gold Nanoantennas for the Induction of a Locoregional Tumor pH Change Using Electrolytic Ablation Therapy-Reference-Cited by-同舟云学术

Electric Field-Responsive Gold Nanoantennas for the Induction of a Locoregional Tumor pH Change Using Electrolytic Ablation Therapy

Published:2024-07-08 Issue: Volume: Page:
ISSN:1936-0851
Container-title:ACS Nano
language:en
Short-container-title:ACS Nano

Author:

Joe Ara¹,Manivasagan Panchanathan¹,Park Jong Kook²,Han Hyo-Won¹,Seo Sun-Hwa¹,Thambi Thavasyappan³,Giang Phan Vu Hoang⁴,Kang Soon Ah²,Conde João⁵^ORCID,Jang Eue-Soon¹^ORCID

Affiliation:

1. Department of Applied Chemistry, Kumoh National Institute of Technology, Daehak-ro 61, Gumi, Gyeongbuk 39177, Republic of Korea

2. Department of Convergence Technology, Graduate School of Venture, Hoseo University, Seoul 06724, Republic of Korea

3. Graduate School of Biotechnology, College of Life Sciences, Kyung Hee University, Yongin-si, Gyeonggi-do 17104, Republic of Korea

4. Biomaterials and Nanotechnology Research Group, Faculty of Applied Sciences, Ton Duc Thang University, Ho Chi Minh City 70000, Vietnam

5. ToxOmics, NOVA Medical School, Faculdade de Ciências Médicas, NMS|FCM, Universidade NOVA de Lisboa, Lisboa 1169-056, Portugal

Funder

Ministry of Health and Welfare

Ministry of Science and ICT, South Korea

National Research Foundation of Korea

Ministry of Education, Science and Technology

European Commission

National Research Foundation of Korea (NRF), South Korea

Publisher

American Chemical Society (ACS)

Link

https://pubs.acs.org/doi/pdf/10.1021/acsnano.4c03610

Reference50 articles.

1. Global, regional, and national burden of colorectal cancer and its risk factors, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019

2. Advanced-stage pancreatic cancer: therapy options

3. Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life Years for 29 Cancer Groups From 2010 to 2019

4. Drug Resistance in Cancer: An Overview

5. Electrolytic ablation enables cancer cell targeting through pH modulation